2NWT

NMR Structure of Protein UPF0165 protein AF_2212 from Archaeoglobus Fulgidus; Northeast Structural Genomics Consortium Target GR83

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	4,3D, GFT HNNCABCA	1.2 mM protein Y2212_ARCFU, U-15N,13C, 5mM CaCl, 100mM NaCl, 20mM NH4OAc, 10mM DTT, 0.02%NaN3	5% D2O, 95% H2O	100 mM NaCl	5.5	ambient	298
2	4,3D, GFT CABCACoNNH	1.2 mM protein Y2212_ARCFU, U-15N,13C, 5mM CaCl, 100mM NaCl, 20mM NH4OAc, 10mM DTT, 0.02%NaN3	5% D2O, 95% H2O	100 mM NaCl	5.5	ambient	298
3	4,3D, GFT HCCH COSY	1.2 mM protein Y2212_ARCFU, U-15N,13C, 5mM CaCl, 100mM NaCl, 20mM NH4OAc, 10mM DTT, 0.02%NaN3	5% D2O, 95% H2O	100 mM NaCl	5.5	ambient	298
4	3D, 15N-13C resolved simultanious NOESY	1.2 mM protein Y2212_ARCFU, U-15N,13C, 5mM CaCl, 100mM NaCl, 20mM NH4OAc, 10mM DTT, 0.02%NaN3	5% D2O, 95% H2O	100 mM NaCl	5.5	ambient	298
5	3D, 15N, 13C resolved X-filtered NOESY	1.2 mM protein Y2212_ARCFU, U-15N,13C, 5mM CaCl, 100mM NaCl, 20mM NH4OAc, 10mM DTT, 0.02%NaN3	5% D2O, 95% H2O	100 mM NaCl	5.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	750
2	Varian	INOVA	600

NMR Refinement
Method	Details	Software
simulated annealing molecular dynamics		NMRPipe

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	20 (lowest energy)

Additional NMR Experimental Information
Details	This Structure was determined using recently developed High Throughput NMR structure determination protocol.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe	2.3	Delaglio et al
2	data analysis	DYANA	1.5	Guntert et al
3	refinement	CYANA	2.1	Guntert et al
4	refinement	CNS	1.1	Brunget et al

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.